You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 4, 2018

Practical Law Life Sciences Global Guide: Pharmaceutical IP and Competition Law in Thailand

Practical Law

The 2018 edition of Thomson Reuters’ Practical Law Life Sciences Global Guide  has been released, with a chapter on Pharmaceutical Intellectual Property and Competition Law in Thailand penned by legal practitioners from Tilleke & Gibbins.

The guide is a Q&A-style overview of the regulatory frameworks of the life sciences industries across multiple jurisdictions worldwide, with this chapter addressing the following issues as they relate to Thailand:

  • Pharmaceutical patent legislation and scope of protection
  • Patent application process, duration of protection, and revocation
  • Patent infringement, claims, and remedies
  • Non-patent barriers to competition for pharmaceutical protection
  • Pharmaceutical trademark legislation and scope of protection
  • Trademark application process, duration of protection, and revocation
  • Trademark infringement, claims, and remedies
  • Regulatory powers and enforcement against pharmaceutical counterfeiting
  • Competition law framework and implications for the pharmaceutical sector
  • Competition issues related to licensing of pharmaceutical technology and patents, and market entry of generic products
  • Market dominance issues in the pharmaceutical sector
  • Parallel imports
  • Foreign patent and trademark licenses, and payment of royalties

Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. Tilleke & Gibbins also drafted a chapter on Medicinal Product Regulation and Product Liability in Thailand for the 2018 edition of the guide.

RELATED INSIGHTS​ 

March 19, 2020
The effects of the global COVID-19 pandemic on Southeast Asia are a deep concern shared by all with connections to the region. To encourage clear understanding of the facts on the ground, Tilleke & Gibbins has prepared this high-level snapshot of the legal situation as it currently stands in each of our jurisdictions.Administrative and Judicial Functions
March 18, 2020
On February 24, 2020, the government of Vietnam issued Decree No. 24/2020/ND-CP (“Decree 24”) providing detailed guidance on the 2019 Law on Prevention and Control of Harmful Effects of Alcoholic Beverages (the “Law on Alcoholic Beverages”), which took effect on January 1, 2020. Among other things, Decree 24 provides further guidance about the restrictions on consumption, advertising, and trading of alcoholic beverages. Below is a summary of these provisions:Consumption of alcoholic beverages
March 2, 2020
Non-communicable diseases (NCDs) mainly consist of cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, and are the most frequent causes of death worldwide. A 2018 World Health Organization (WHO) fact sheet on NCDs notes that 41 million people die annually from NCDs (71% of global deaths), including 15 million people who die before the age of 70.